A multicenter, randomized clinical trial involving 321 patients in China compared the efficacy and toxicity of paclitaxel with fluorouracil, cisplatin or carboplatin in definitive chemoradiotherapy ...

Department of Otorhinolaryngology- Head and Neck Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Republic of Korea ...

CX-4945 Monotherapy: Progression-free survival (PFS) exceeded 21 months in two patients. Optimal Treatment Response: Three patients achieved partial response (PR), while ten patients had stable ...

in the Treatment of Basal Cell Carcinoma(BCC), with positive data outcomes. The study included patients who had relapsed after standard therapies and had no other treatment options. Among them, three ...

CX-4945 Monotherapy: Progression-free survival (PFS) exceeded 21 months in two patients. Optimal Treatment Response: Three patients achieved partial response (PR), while ten patients had stable ...

When it comes to minimizing tissue hyperplasia ... the diagnosis was esophageal cancer (Figure 4A). Pathological examination of the biopsy taken from the “esophagus at 28–31 cm” confirmed moderately ...

In stark contrast, EsoCheck's soft and gentle, targeted and protected approach to noninvasive esophageal cell collection has resulted in a pristine safety record with no device failures after ...